Details

Last Funding Type

Debt Financing

Last Funding Money Raised

$35M

Industries

Biotechnology,Genetics,Health Diagnostics,Medical

Founded date

Jan 1, 2016

Number Of Employee

101 - 250

Operating Status

Active

Legal Name

BillionToOne, Inc.

BillionToOne is a precision diagnostics company that quantifies biology to create molecular diagnostics accurate, efficient, and accessible for all. The company's patent-pending molecular counter platform is a technology platform that can accurately count the DNA molecules to the single-count level. BillionToOne's mission is to make pre-natal testing safe and affordable for every expecting mother. Its novel technology can detect even single-gene disorders such as thalassemia through a simple blood test. They are replacing amniocentesis, an invasive and risky procedure that has a high miscarriage risk, with a safe and affordable blood test, starting with developing countries.

BillionToOne was founded in 2016 and is headquartered in Menlo Park, California.